Prognostic significance of branched-chain amino acid transferase 1 and CD133 in triple-negative breast cancer

BMC Cancer

Table 3 Correlation of TNBC prognosis with BCAT1 and CD133 expressions

Variable	No. of Patient	DFS		P	OS		P
Variable	No. of Patient	No. of event	Estimated 5-year surviving rate (standard error)	P	No. of event	Estimated 5-year surviving rate (standard error)	P
cohort	291	83	72.2% (2.6%)	–	53	81.6% (2.3%)	–
BCAT1 expression
Low	205	44	78.8% (2.9%)	P < 0.001	27	86.8% (2.4%)	P < 0.001
High	86	39	56.3% (5.4%)	P < 0.001	26	68.7% (5.2%)	P < 0.001
CD133 expression
Low	197	44	79.0% (2.9%)	P < 0.001	25	87.4% (2.4%)	P < 0.001
High	94	39	57.5% (5.2%)	P < 0.001	28	68.7% (5.0%)	P < 0.001
BCAT1 + CD133 expression
Both-low expression	147	26	82.9% (3.1%)	P < 0.001	13	90.8% (2.4%)	P < 0.001
mixed expression	108	35	68.0% (4.5%)		27	76.8% (4.2%)
both-high expression	36	21	39.9% (8.3%)		14	55.0% (9.1%)

ISSN: 1471-2407